15017 Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure

ABSTRACT IMPACT: Younger patients receiving biologics for rheumatoid arthritis have higher medical expenditure. OBJECTIVES/GOALS: TNF inhibiting biologic disease modifying antirheumatic drugs are among the most highly regarded treatment options for rheumatoid arthritis (RA). We aimed at evaluating t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Robert A., Ceacareanu, Alice C., Wintrob, Zachary A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Clinical Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827817/
http://dx.doi.org/10.1017/cts.2021.478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827817/
http://dx.doi.org/10.1017/cts.2021.478

Ejemplares similares